GlassScriptPhysician profile
Tracy Ann Proctor
NPI 1306489174
$1,597.91
in general payments reported to CMS, 2019-2025
15 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.83 · 2022: $869 · 2023: $490 · 2024: $41.49 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $583.39 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $248.82 | 2022-2023 | Austedo, Austedo Xr |
| Vanda Pharmaceuticals INC. | $182.04 | 2022 | |
| Janssen Biotech, INC. | $129.78 | 2025 | Simponi Aria, Tremfya |
| Alkermes, INC. | $91.49 | 2024-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $77.54 | 2022-2023 | Ingrezza |
| Janssen Pharmaceuticals, INC | $68.90 | 2022-2023 | Spravato |
| Almatica Pharma LLC | $41.29 | 2022-2023 | Sertraline Hcl, Loreev Xr |
| Idorsia Pharmaceuticals US INC | $39.10 | 2022-2023 | Quviviq |
| Corium, LLC | $35.36 | 2023 | Azstarys |
| Neos Therapeutics, LP | $35.21 | 2022-2023 | Adzenys Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $18.52 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $17.83 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.62 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.